Evaluation of Killing Kinetics of Anti-Tuberculosis Drugs on Mycobacterium tuberculosis Using a Bacteriophage-Based Assay

Publisher： Karger

E-ISSN： 1421-9794|54|5|404-411

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.5, 2008-09, pp. : 404-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tuberculosis Drugs and Human Polymorphonuclear Leukocyte Functions

By  

Chemotherapy, Vol. 57, Iss. 4, 2011-09 ,pp. : 339-344

Karger

Access to resources Recommend Favorite

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates

By Fauziyah Prabasiwi Nur   Sukandar Elin Yulinah   Ayuningtyas Dhyan Kusuma  

Scientia Pharmaceutica, Vol. 85, Iss. 1, 2017-03 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action

By Amaral Leonard   Viveiros Miguel  

Antibiotics, Vol. 6, Iss. 1, 2017-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis

By  

Chemotherapy, Vol. 61, Iss. 5, 2016-03 ,pp. : 249-255

Karger

Access to resources Recommend Favorite

Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-05 ,pp. : 269-278

Karger

Access to resources Recommend Favorite